Department of Ankara Research and Training Hospital. We considered 30 female patients who were diagnosed with migraine according to the diagnostic criteria of the International Headache Society (IHS) published in 1988 [5] .
The 30 patients were asked to keep a headache daily which consisted of questions about the days with headache, localisation, laterality, intensity of pain, presence of nausea, vomiting, photophobia and phonophobia, and whether the pain increased with walking or not. The intensity of pain was scored on a visual analog scale (VAS) in which 0 represented no pain and 10 meant the worst pain imaginable. Menstrual cycles of the patients were regular. None of the patients used oral contraceptives.
After evaluation of the patients with their dairies, 15 patients whose headache met the definition of MM by MacGregor et al. [1] were included in the study. These patients were followed for two cycles of menstrual periods. The patients were informed about the study and none of the patients used antimigraine treatments during the study period. We noticed their menstruation and migraine attacks.
Fourteen days before the next expected menstruation period was accepted as probable ovulation time. Thus, brain SPECT was performed at this time (midcycle), which was chosen individually for each patient. The patients did not have headache in probable ovulation time. Brain SPECT was performed during the MM attack. The patients phoned us when they had MM attack and went to the hospital for SPECT analysis.
Brain SPECT was performed with rotating gamma camera system. Five minutes before SPECT, 15 mCi Tc 99 HMPAO was injected intravenously with the patient lying supine with eyes closed. Data were acquired in a 64x64 matrix through 360º rotation at intervals for 15 seconds per view.
Two experienced nuclear medicine physicians, who had no clinical information about the patients, did visual interpretation of the cortical uptake. Attention was given to the presence of any brain perfusion abnormality. Quantitative evaluation of the cortical uptake was evaluated with Ceretec pocket programme. Regions of interest were drawn on the images to generate mean counts per pixel, and normalized to the cerebellum. Perfusion activities in the frontal, temporal, parietal, and occipital cortices were compared between midcycle and MM attack.
Wilcoxon's matched pairs (signed ranks) and ANOVA tests were employed for statistical analysis. A p value < 0.05 was accepted to be statistically significant.
Results
The mean age of the 15 patients with menstrual migraine (MM) was 37.8 years (SD, 8.0 years). Mean MM migraine duration was 13.0 years (SD, 1.2 years) and mean pain duration was 2.5 days (SD, 0.7 days). The intensity of pain, as scored on VAS, was 7.9±1.5 (mean±SD). MM attacks generally occurred on day 1 or 2 of the menstrual cycle (1.0±0.5, mean±SD).
Of the 15 patients with MM, 4 (27%) had migraine with aura and 11 (73%) had migraine without aura (Table 1) . There was no statistically significant difference between the 2 subgroups in the duration or timing of MM attack. All the patients had only one migraine attack during menstruation. The headache was unilateral in 6 cases (40%) and bilateral in 9 cases (60%). Brain SPECT was performed on day 1 or 2 of the MM attack (mean±SD, 1.5±0.5). None of the patients reported headache lasting less than 1 day.
In the visual evaluation, we observed hypoperfusion in 7 of the 15 patients during MM attack ( Table 1 ). Four of these 7 patients, specifically the 4 patients with migraine with aura, had normal perfusion in the middle of the cycle. The hypoperfusion areas revealed during the MM attack in these patients were the right occipital lobe two patients, in the right temporal lobe in one patient and the left parietal lobe in the remaining patient. Hypoperfusion was observed both during the MM attack and in the middle of the menstrual cycle, in 3 of the 15 patients (Table 1) . Hypoperfusion was observed in 4 other patients at midcycle but not during the MM attack, and the final 4 patients had no evidence of brain hypoperfusion
We quantitatively compared the perfusions of the frontal lobes, temporal lobes, parietal lobes and occipital lobes during the MM attack and in the middle of the menstrual cycle with Ceretec programme. There was no statistically significant difference in perfusion activities between the two monitoring periods for any patient (p>0.05) ( Table 2) . Putting the data together, independently from the pattern of each patient, we also compared cerebral blood flow in midcycle and MM attack, but the difference did not reach the level of statistical difference for patients with migraine without aura (data not shown). No comparison was possible for MWA patients due to the small number of patients.
Discussion
The pathogenesis of migraine has not yet been defined clearly. Neurogenic, vascular and humoral factors are putative mechanisms involved [8] [9] [10] [11] .
In particular, two theories have been proposed to explain migraine pathogenesis and the debate still continues. The first is the transient cerebral arterial constriction that causes reduced brain perfusion and migraine aura while the subsequent headache results from the intra-and/or extracranial arterial vasodilatation. The second one is cortical spreading depression, which induces an oligemia originating in the posterior brain and progressing anteriorly, and vascular abnormalities are considered only secondary phenomena [11, 12] .
The pathogenetic mechanisms underlying mestruationassociated migraine attacks are scarcely known. Estrogen withdrawal can postpone the migraine [13] [14] [15] [16] . One report suggested that MM attacks could be prevented by suppressing the progesterone-estrogen fluctuation in menstrual cycle [17] . Other authors, on the contrary, have not supported the hormonal theory because hormonal therapy is not beneficial to every patient suffering from MM and sometimes it worsens the attacks in terms of increased frequency and intensity [13, 18] . Additional studies stated that not only estrogen and progesterone but also prostaglandin and magnesium deficiency took part in MM pathogenetic mechanisms [13, 15, 18] . Other abnormalities have been shown in menstrual migraine patients such as changes in the level of prolactin, dysregulation of opioids, disordered sympathetic activity, impaired carbohydrate tolerance, platelet dysfunction, vitamin deficiencies and inherited immune pattern [19] . Neurogenic mechanisms have also been hypothesized in MM attacks but few studies have been performed until now in this regard. Among them, a brainstem auditory evoked response (BAER) study revealed a neural abnormality which might be at brainstem level [16] and electroencephalographic findings showed a significant increase in mean alpha amplitude, theta activity and mild paroxysms, particularly in premenstrual syndrome [17] .
It has been known for several years that vascular changes occur during migraine attacks but no studies have been carried out until now on mestruation-associated migraine attacks. Changes in rCBF were found in migraineurs, assessed in interictal periods [20] [21] [22] [23] [24] [25] [26] .
On the other hand, hormonal variations (in particular estrogen levels) have been evidenced to induce an increase in the cerebral blood flow velocity and pulsatility indices [27] . Moreover, haemodynamic changes have been found at different phases in the menstrual cycle and also higher standard Doppler indices have been demonstrated in the luteal phase compared to the follicular phase in the middle cerebral artery (MCA) [28] . Increased ventilation and subsequent lowering of alveolar CO 2 pressure, secondary to a raised progesterone level in mid-luteal phase, could account for the observed changes within the MCA [28] . Studies of cerebral perfusion during MM attack are lacking until now. In our study we found hypoperfusion during MM attack in 7 patients. Three of these patients had hypoperfusion also at midcycle. In 2 of these cases, hyperfusion was observed in the same brain areas during MM attack as during midcycle.
On the other hand, hypoperfusion was evident in 3 patients at parietal and 1 at temporal area and only at midcycle in 4 patients. As far as the midcycle is concerned, we were unable to verify the occurrence of ovulation because no methods such as body basal temperature or urinary sticks were used. This limits the possibility of demonstrating a clear relation between midcycle cerebral haemodynamic changes with hormonal ovulation, and we cannot discriminate whether the changes observed are related to these physiological variations or are, on the contrary, peculiar of migraine patients.
The different pattern observed among patients at midcycle could be related to the occurrence or non-occurrence of ovulation but no conclusion of this can be made due to the lack of definite evidence.
In this regard it should be pointed out that variations of brain perfusion should be verified also in healthy subjects not suffering from headache. The changes in cerebral haemodynamics should be finally investigated in women with non-menstrual migraine examined at midcycle.
As far as the hypoperfusion is concerned (during menstrual migraine attack), both neuronal and vascular changes are already favoured by estrogen withdrawal. However, no explanation can be given for the cases in which these changes have not been observed.
Further studies investigating cerebral blood flow, also involving attacks not associated with mestruation, should be carried out in this regard. This should allow us to discriminate whether a different pattern of cerebral haemodynamic changes is evidenced in MM and non-MM. They should involve cerebral SPECT, Doppler ultrasound and MCA evaluation.
